Breast cancer medications, called aromatase inhibitors, may lessen the effect of weight loss drugs, according to a new study being presented Friday at ENDO 2023, the Endocrine Society’s annual meeting in Chicago, Ill.
The study found that weight loss medications are less effective in breast cancer survivors who are treated with aromatase inhibitors, compared with women without a history of breast cancer who are not taking aromatase inhibitors.